Novo Nordisk NVO shares have gained 5.8% in a week. The uptrend in the stock price was driven by reports of an activist hedge ...

Hims and Hers stock rally looms with bullish EMAs, Novo Nordisk partnership, ZAVA acquisition, and new product launches ...

Novo Nordisk (NYSE: NVO) has permanently forfeited Canadian patent protection for semaglutide—the blockbuster active ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Similarly, experts suggest that type two diabetes drug Ozempic, could actually be increasing penis sizes via illusion.

Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

Semaglutide medications like Ozempic and Wegovy have shown proven results for managing conditions like type 2 diabetes and ...

Despite the jump in the number of teens being prescribed Wegovy, it still represents only a small fraction of kids who are living with obesity. Approximately one in 5 children and teens in the U.S.

Kyle Richards is ‘monitoring’ daughter Sophia diet after she admitted to experiencing hair loss after taking Mounjaro, a source exclusively tells Life & Style.

ETFs tracking the performance of weight-loss drugs have largely underperformed since launching in late 2023. GLP-1 investors haven’t gained as much as expected from others’ losses.

Experts have issued an urgent warning about a symptom that can come to light from taking drugs such as Mounjaro and Ozempic.

The New Science of Achieving a Healthy Weight” (Flatiron Books), former FDA Commissioner David A. Kessler argues that ultraprocessed foods — meaning ...